Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole PK/PD in boys with gynecomastia
NCT00241436Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2005
- Primary completion
- Nov 2006
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of anastrozole in gynecomastia, sponsored by AstraZeneca. Primary endpoint: Pharmacokinetics. Started Jun 2005; status: completed.
02
Drugs
anastrozole
03
Conditions
gynecomastia
Beyond the preview
Go deeper on NCT00241436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241436.